1. Addition of four doses of rituximab to standard induction chemotherapy in adult patients with precursor B-cell acute lymphoblastic leukaemia (UKALL14): a phase 3, multicentre, randomised controlled trial. Issue 4 (April 2022) Authors: Marks, David I; Kirkwood, Amy A; Rowntree, Clare J; Aguiar, Melanie; Bailey, Katharine E; Beaton, Brendan; Cahalin, Paul; Castleton, Anna Z; Clifton-Hadley, Laura; Copland, Mhairi; Goldstone, Anthony H; Kelly, Richard; Lawrie, Emma; Lee, SooWah; McMillan, Andrew K; McMullin, Mary Frances; Menne, ... Journal: Lancet Issue: Volume 9:Issue 4(2022) Page Start: e262 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗